Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University of Zurich
ClinicalTrials.gov Identifier:
NCT01598805
First received: May 11, 2012
Last updated: November 15, 2012
Last verified: November 2012

May 11, 2012
November 15, 2012
June 2012
September 2012   (final data collection date for primary outcome measure)
Rate of prophylaxis against venous thromboembolism [ Time Frame: 3 months ] [ Designated as safety issue: No ]
patients with prophylaxis/total patients
Same as current
Complete list of historical versions of study NCT01598805 on ClinicalTrials.gov Archive Site
  • ordering time after admission or transfer of a patient [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    time when physicians order a venous thromboembolism prophylaxis
  • acceptance of the eAlerts [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    survey of compliant and incompliant physicians
Same as current
Not Provided
Not Provided
 
Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts
Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts

Now, after a cluster randomized controlled trial, eAlerts providing evidence-based guidelines on venous thromboembolism prophylaxis will be rolled out and evaluated hospital-widely.

An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer. The eAlerts provide evidence-based guidelines on venous thromboembolism prophylaxis. Now, after a cluster randomized controlled trial, the eAlerts will be rolled out and evaluated hospital-widely.

Interventional
Not Provided
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Subject)
Primary Purpose: Health Services Research
Venous Thromboembolism
Behavioral: electronic alerts
An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer.
Other Name: eAlert
Experimental: roll out of eAlerts
Roll out of eAlerts providing evidence-based guidelines on prophylaxis against venous thromboembolism. An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer.
Intervention: Behavioral: electronic alerts
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
10000
September 2012
September 2012   (final data collection date for primary outcome measure)

Inclusion criteria:

  • all in-patients hospitalized in a ward with computerized physician order entry (CPOE),
  • staying at least 24 h in a ward

Exclusion criteria:

  • outpatients,
  • ward without CPOE,
  • patients transferred from an intervention to a control ward and vice versa
Both
16 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Switzerland
 
NCT01598805
FZMI-KEK-ZH-Nr. 2010-0458
No
University of Zurich
University of Zurich
Not Provided
Principal Investigator: Juerg Blaser, Prof. PhD University Hospital Zurich, Center for Clinical Research, Research Center for Medical Informatics
University of Zurich
November 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP